The Short Form-36: Pre- Versus Post-Surgical Administration in Cardiac Surgery Patients
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00226265
: September 26, 2005
Last Update Posted
: February 23, 2017
Weill Medical College of Cornell University
Information provided by (Responsible Party):
Mary E. Charlson, MD, Weill Medical College of Cornell University
The purpose of this study is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.
The purpose of this study, is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 100 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Cardiac Surgery Patients at New York Presbyterian Hospital-Weill Cornell Medical College
Cardiac surgery patients who are between the ages of 18 and 100
Are English speaking
Able to give consent
Undergoing cardiac surgery including (but not limited to):